FemCare start-up Daye raised $5.5 million in seed funding from high-profile investors in the US and Europe and will be launching later this year.
WHO: London-based FemCare start-up Daye, founded by 24-year-old Valentina Milanova, is developing a new type of tampon that uses CBD to help tackle period cramps (or dysmenorrhea) as an alternative to traditional painkillers. Daye also claims its product will be more hygienic and sustainable than legacy tampons.
WHY: The capital will be used towards growing the team and launching a production facility.
IN THEIR OWN WORDS: “Our goal is to raise the standards of women’s hygiene products by tackling three primary issues: dysmenorrhea, manufacturing standards and sustainability,” Milanova tells TechCrunch. “Women have largely been left out of medical innovation. In fact, until 1993, researchers banned women from participating in [early] clinical trials, as it was believed female hormone fluctuations polluted medical data. To this day, most medications, including those for pain relief, depression, and sleeping aids, have not been tested on women. We’re redefining localised cramp-relief, relying on an ingredient that we’ve tested on women first.”
DETAILS:
